Sign In
By signing in or creating an account, you agree with Associated Broadcasting Company's Terms & Conditions and Privacy Policy.
By signing in or creating an account, you agree with Associated Broadcasting Company's Terms & Conditions and Privacy Policy.
Kolkata: The markets ended deep in the red on Tuesday, Dec 17, 2025. At close of trade, Sensex 30 was at 84,679.86, down 533.50 points or 0.63%, while Nifty 50 was at 25,860.10, down 167.20 points or 0.64%.
The stocks to watch today include NBCC, Kaynes Technology and HCL Tech. On Tuesday, Dec 16, there was wide selling in some banking stocks and Axis Bank stock fell more than 4%. While decline in heavyweight stocks dragged the Nifty down, there was concern since it settled below 25,900. Quite a few stocks can move based on news and corporate developments today.
Kaynes Technology India: Kaynes Semicon, which is a subsidiary of Kaynes Technology India, has announced partnerships with two global companies. One a strategic partnership with AOI Electronics and another with Mitsui & Co of Japan. These agreements are intended to strengthen semiconductor manufacturing operations originating in India.
HCL Technologies: This is positive development for HCLTech. NSE Academy has partnered with HCLTech to launch joint certificate programs in technology and finance. These courses aim to develop future-ready skills for the banking, insurance, financial markets, and fintech sectors.
NBCC India: NBCC India has received a couple of new orders -- a project management consultancy order worth Rs 332 crore from IIT Mandi and an annual maintenance work worth Rs 12 crore from Kandla SEZ.
Akzo Nobel India: According to news reports, promoter Imperial Chemical Industries may sell up to 9% of its stake in this company through a block deal. The total size of this offer is reportedly about Rs 1,290 crore. The floor price has been set at Rs 3,150 per share.
Ahluwalia Contracts India: Ahluwalia Contracts has won a deal worth Rs 888 crore from the Bihar State Tourism Development Corporation and it is related to the construction and overall development of the Shri Ram Janmabhoomi Teerth Kshetra, Ayodhya, located in Punauradham, Bihar. Project to be executed on EPC mode.
Saregama: Saregama has entered into a major investment agreement with Bhansali Productions. The company has purchased 9,960 compulsorily convertible preference shares of Bhansali Productions for Rs 325 crore. The board has also approved the purchase of additional equity in subsequent tranches. The company could acquire up to a 51% stake in Bhansali Productions by March 2030.
Glenmark Pharmaceuticals: Glenmark's subsidiary, Glenmark Specialty SA, has struck a licensing and distribution agreement with Hansoh Pharma for lung cancer drug Aumolertinib. Hansoh Pharma will receive an initial payment of several million dollars, with the total payment expected to exceed $1 billion based on further regulatory and commercial milestones.
Indian Overseas Bank: The government's stake sale in Indian Overseas Bank begins today. The government will sell about 38 crore shares, or 2% stake, on December 17 and 18. It will also have the option to sell an additional 1% stake. The floor price is Rs 34 per share.
Sequent Scientific: Sequent Scientific has undergone significant management changes. The company has appointed Haribabu Bodepudi as MD and Group CEO for a two-year term. Rajaram Narayanan has also been appointed Whole-Time Director and CEO of Animal Health. Ramakant Singani has also been approved as CFO effective January 1, 2026.
Kajaria Ceramics: Shareholders have approved the appointment of Ashok Kajaria as chairman, Chetan Kajaria as vice chairman, and Rishi Kajaria as MD.
(Disclaimer: This article is only meant to provide information. News9 does not recommend buying or selling shares or subscriptions of any IPO, Mutual Funds, precious metals, commodity, any form of alternative investment instruments and crypto assets.)
